Compare ADV & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADV | NVCT |
|---|---|---|
| Founded | 1987 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 523.2M | 617.7M |
| IPO Year | 2019 | 2021 |
| Metric | ADV | NVCT |
|---|---|---|
| Price | $33.09 | $23.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $45.83 | $10.00 |
| AVG Volume (30 Days) | 62.6K | ★ 173.5K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,542,642,000.00 | N/A |
| Revenue This Year | $0.63 | N/A |
| Revenue Next Year | $0.45 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.49 | $5.55 |
| 52 Week High | $47.45 | $29.28 |
| Indicator | ADV | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 50.63 |
| Support Level | $0.70 | $17.98 |
| Resistance Level | $35.50 | $23.12 |
| Average True Range (ATR) | 1.68 | 1.53 |
| MACD | 0.06 | -0.25 |
| Stochastic Oscillator | 55.25 | 12.21 |
Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.